Technology ID
TT-0108
Description
This technology discovers and validates blood biomarkers for the early detection and progression monitoring of neurodegenerative diseases, creating opportunities for improved diagnosis and therapeutic development.
Content
Discovery Platform: Human bio-data analytics enable systematic identification of novel blood biomarkers and their regulatory pathways
Biological Validation: Preclinical studies in human cells and mouse models confirm the functional relevance of candidate biomarkers
Translation Capability: Established platforms exist for developing therapeutic modalities targeting identified pathways, with preliminary drug hits available for selected targets
Clinical Utility Potential: Blood biomarkers support diagnostics, prognosis, and drug-response monitoring, creating opportunities for personalized treatment strategies
Inventors
Applicable Industries
Potential Application
Technology Focus
TRL
Images
